Antibodies for Use as Therapeutics Against Bacterial Infections
AssigneeKymab Limited
InventorsStephen REECE, Aisha KRISHNA, Siobhan O'LEARY, Josefin BARTHOLDSON SCOTT, Simon WATSON, Stephen BAKER
Life of this patent
Estimating the term…
Abstract
The present invention relates to antibodies that bind Acinetobacter baumannii, and their use in the diagnosis of, and the prevention and treatment of, bacterial infection caused by Acinetobacter baumannii. In particular, the present invention relates to monoclonal antibodies that specifically bind at the bacterial wall of Acinetobacter baumannii bacteria, such as on, e.g., living bacteria.
Claims81
An antibody that specifically binds at the surface of Acinetobacter baumannii bacteria.
An antibody according to any one of the preceding claims, wherein the antibody shows complement-dependant cytotoxic activity (CDC) activity.
An antibody according to any one of the preceding claims, wherein the antibody is a human IgG1 or human IgG4.
A nucleic acid sequence comprising a sequence that encodes a VH domain and/or an VL domain of an antibody according to any preceding claim.
A nucleic acid sequence comprising a sequence that encodes the heavy chain and/or the light chain of an antibody according to any preceding claim.
A method of determining the presence or absence of Acinetobacter baumannii in a sample comprising contacting the sample with an antibody according to any one of 1 to 35;
- and testing for binding between the antibody and Acinetobacter baumannii in the sample;
- wherein detection of binding indicates the presence of Acinetobacter baumannii in the sample and wherein absence of binding indicates the absence of Acinetobacter baumannii in the sample.
Dependencies are inferred from the claim text.